vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $32.2M, roughly 1.1× OptimizeRx Corp). OptimizeRx Corp runs the higher net margin — 15.6% vs -1.8%, a 17.4% gap on every dollar of revenue. On growth, OptimizeRx Corp posted the faster year-over-year revenue change (-0.2% vs -3.2%). OptimizeRx Corp produced more free cash flow last quarter ($7.1M vs $-2.4M). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CLFD vs OPRX — Head-to-Head

Bigger by revenue
CLFD
CLFD
1.1× larger
CLFD
$34.3M
$32.2M
OPRX
Growing faster (revenue YoY)
OPRX
OPRX
+3.0% gap
OPRX
-0.2%
-3.2%
CLFD
Higher net margin
OPRX
OPRX
17.4% more per $
OPRX
15.6%
-1.8%
CLFD
More free cash flow
OPRX
OPRX
$9.5M more FCF
OPRX
$7.1M
$-2.4M
CLFD
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
OPRX
OPRX
Revenue
$34.3M
$32.2M
Net Profit
$-614.0K
$5.0M
Gross Margin
33.2%
74.8%
Operating Margin
-5.3%
26.6%
Net Margin
-1.8%
15.6%
Revenue YoY
-3.2%
-0.2%
Net Profit YoY
67.8%
6535.9%
EPS (diluted)
$-0.04
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
OPRX
OPRX
Q4 25
$34.3M
$32.2M
Q3 25
$23.4M
$26.1M
Q2 25
$49.9M
$29.2M
Q1 25
$47.2M
$21.9M
Q4 24
$29.7M
$32.3M
Q3 24
$5.6M
$21.3M
Q2 24
$48.8M
$18.8M
Q1 24
$36.9M
$19.7M
Net Profit
CLFD
CLFD
OPRX
OPRX
Q4 25
$-614.0K
$5.0M
Q3 25
$-9.1M
$779.0K
Q2 25
$1.6M
$1.5M
Q1 25
$1.3M
$-2.2M
Q4 24
$-1.9M
$-78.0K
Q3 24
$-9.1M
Q2 24
$-447.0K
$-4.0M
Q1 24
$-5.9M
$-6.9M
Gross Margin
CLFD
CLFD
OPRX
OPRX
Q4 25
33.2%
74.8%
Q3 25
53.2%
67.2%
Q2 25
30.5%
63.8%
Q1 25
30.1%
60.9%
Q4 24
29.2%
68.1%
Q3 24
63.1%
Q2 24
21.9%
62.2%
Q1 24
7.7%
62.0%
Operating Margin
CLFD
CLFD
OPRX
OPRX
Q4 25
-5.3%
26.6%
Q3 25
10.3%
7.9%
Q2 25
3.0%
10.9%
Q1 25
0.6%
-9.6%
Q4 24
-6.9%
11.2%
Q3 24
-40.2%
Q2 24
-4.7%
-19.9%
Q1 24
-26.4%
-25.5%
Net Margin
CLFD
CLFD
OPRX
OPRX
Q4 25
-1.8%
15.6%
Q3 25
-38.8%
3.0%
Q2 25
3.2%
5.2%
Q1 25
2.8%
-10.0%
Q4 24
-6.4%
-0.2%
Q3 24
-42.8%
Q2 24
-0.9%
-21.3%
Q1 24
-16.0%
-35.0%
EPS (diluted)
CLFD
CLFD
OPRX
OPRX
Q4 25
$-0.04
$0.27
Q3 25
$-0.65
$0.04
Q2 25
$0.11
$0.08
Q1 25
$0.09
$-0.12
Q4 24
$-0.13
$0.00
Q3 24
$-0.50
Q2 24
$-0.04
$-0.22
Q1 24
$-0.40
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$96.4M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$249.7M
$128.3M
Total Assets
$268.1M
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
OPRX
OPRX
Q4 25
$96.4M
$23.4M
Q3 25
$106.0M
$19.5M
Q2 25
$117.2M
$16.6M
Q1 25
$112.0M
$16.6M
Q4 24
$113.0M
$13.4M
Q3 24
$129.0M
$16.1M
Q2 24
$123.8M
Q1 24
$142.9M
Total Debt
CLFD
CLFD
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$2.2M
$36.8M
Q2 24
$2.1M
$37.3M
Q1 24
$37.8M
Stockholders' Equity
CLFD
CLFD
OPRX
OPRX
Q4 25
$249.7M
$128.3M
Q3 25
$256.2M
$122.3M
Q2 25
$264.5M
$119.3M
Q1 25
$265.9M
$116.3M
Q4 24
$267.4M
$117.0M
Q3 24
$275.8M
$114.5M
Q2 24
$274.6M
$121.0M
Q1 24
$279.2M
$122.5M
Total Assets
CLFD
CLFD
OPRX
OPRX
Q4 25
$268.1M
$176.9M
Q3 25
$306.2M
$170.3M
Q2 25
$314.7M
$169.3M
Q1 25
$310.9M
$167.8M
Q4 24
$303.2M
$171.2M
Q3 24
$315.3M
$165.2M
Q2 24
$318.1M
$172.9M
Q1 24
$315.4M
$176.4M
Debt / Equity
CLFD
CLFD
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.01×
0.32×
Q2 24
0.01×
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
OPRX
OPRX
Operating Cash FlowLast quarter
$-1.4M
$7.1M
Free Cash FlowOCF − Capex
$-2.4M
$7.1M
FCF MarginFCF / Revenue
-7.1%
22.0%
Capex IntensityCapex / Revenue
2.9%
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
OPRX
OPRX
Q4 25
$-1.4M
$7.1M
Q3 25
$3.2M
Q2 25
$7.9M
$4.6M
Q1 25
$3.0M
$3.9M
Q4 24
$7.2M
$198.0K
Q3 24
$22.2M
$1.8M
Q2 24
$4.0M
$782.0K
Q1 24
$-5.7M
$2.1M
Free Cash Flow
CLFD
CLFD
OPRX
OPRX
Q4 25
$-2.4M
$7.1M
Q3 25
$3.2M
Q2 25
$7.5M
$4.6M
Q1 25
$654.0K
$3.8M
Q4 24
$5.1M
$181.0K
Q3 24
$18.2M
$1.8M
Q2 24
$2.8M
$737.0K
Q1 24
$-7.7M
$2.1M
FCF Margin
CLFD
CLFD
OPRX
OPRX
Q4 25
-7.1%
22.0%
Q3 25
12.2%
Q2 25
15.1%
15.6%
Q1 25
1.4%
17.5%
Q4 24
17.1%
0.6%
Q3 24
323.0%
8.3%
Q2 24
5.8%
3.9%
Q1 24
-20.8%
10.6%
Capex Intensity
CLFD
CLFD
OPRX
OPRX
Q4 25
2.9%
0.0%
Q3 25
2.0%
0.0%
Q2 25
0.8%
0.0%
Q1 25
5.1%
0.1%
Q4 24
7.0%
0.1%
Q3 24
71.4%
0.1%
Q2 24
2.5%
0.2%
Q1 24
5.3%
0.2%
Cash Conversion
CLFD
CLFD
OPRX
OPRX
Q4 25
1.41×
Q3 25
4.11×
Q2 25
4.93×
2.98×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons